Moving forward, companies in the drug supply chain located in the United States must continue to implement important changes to their business in order to meet future DSCSA milestone requirements including but not limited to serialization and lot and serial number verification. In this video, Riya explains what companies face with 2017 DSCSA milestones quickly approaching. For one, 2017 is the deadline for imprinting serial numbers on the smallest salable unit level and the case level. Watch the video to hear an explanation of more essential upcoming requirements for manufacturers, repackagers and wholesale distributors.
Recent Posts
Subscribe to the LSPediA Newsletter
LSPediA Explains FDA Draft Guidance on DSCSA
LSPediA Customer Advisory Board: Compliance Guarantee, EPCIS Deadlines, and FDA Draft Guidance
Intensive, Interactive DSCSA Training with LSPediA
LSPediA to join HDA Traceability Seminar in Washington, D.C.
Meet LSPediA at the SpartanNash Pharmacy Conference on September 28!
LSPediA-sponsored HDA Webinars Tackle DSCSA Traceability
